期刊文献+

腹膜透析患者骨密度测定与骨折风险评价 被引量:9

Evaluation of bone mineral density and risk factors for fractures in CAPD patients
下载PDF
导出
摘要 目的观察腹膜透析患者骨密度改变及分析相关因素,为骨质疏松早期诊断和预防骨折发生提供临床依据。方法选择上海交通大学医学院附属瑞金医院肾内科84例慢性肾衰竭腹膜透析患者,以双能X线吸收(dual energy X-ray absorptiometry,DEXA)骨密度仪测定腰椎和股骨近端骨密度,同时采集其临床、生化指标及X线平片。结果 11.9%腹膜透析患者骨质疏松,36.9%骨量减少。骨质疏松多元回归分析入选变量为性别、年龄、体质量指数、尿素清除指数(Kt/V)和尿量。这些患者自腹膜透析始骨折总发生率为9.5%。进入骨折Cox回归模型是腰椎Z值和股骨颈Z值及体质量指数。结论透析不充分、低体质量指数、老年、女性、残余尿量少可能是腹膜透析患者骨质疏松重要危险因素。腰椎和股骨颈Z值可预测腹膜透析患者骨折发生,低体质量指数是腹膜透析患者骨折独立高危因素。 Objective In order to investigate the determinant factors for bone mineral density (BMD) and the risk factors for osteoporotic fractures in CAPD patients. Methods Eight-four CAPD patients were included in this study. BMD was assessed by dual energy X-ray absorptiometry (DEXA) of lumbar spine and femoral neck. Clinical data and laboratory indices as well as X-ray plain were collected. Results Osteoporosis was found in 11. 9% of the 84 patients,and osteopenia in 36.3% patients. Independent variables entering into logistic regression of osteoporosis were sex,age,BMI,Kt/V(P0.01)and daily urine output (P0.05). The overall prevalence of fractures since the initiation of peritoneal dialysis was 9.52%. In Cox regression model,fractures were associated with lumbar spine Z-score,femoral neck Z score and BMI. Conclusions Inadequacy of dialysis,low BMI,older age,female and reduced daily urine output may be the important risk factors for osteoporosis in CAPD patients. Lumbar spine and femoral neck Z scores can predict the occurrence of fractures. Among these factors,low BMI is the most important risk factor for fractures in chronic PD patients.
出处 《中国血液净化》 2010年第6期302-306,共5页 Chinese Journal of Blood Purification
关键词 腹膜透析 骨密度 双能X线吸收 骨质疏松 骨折 Peritoneal dialysis Bone mineral density DEXA Osteoporosis Fracture
  • 相关文献

参考文献22

  • 1Hartmut M, Faugere MC. Renal bone disease: A challenge for the nephrologist[J]. Kidney Int, 1990,38:193 203.
  • 2IsaiaC, C, Tamone C, Ravazzoli M. Fractures and chronic renal insufficiency[J]. G Ital Nefrol, 2008,25:57-65.
  • 3World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis [R]. Geneva:World Health Organization, 1994.
  • 4Christiansen C. Osteoporosis: Diagnosis and management today and tnmorrow[J]. Bone, 1995,17:s513-516.
  • 5Ersoy FF. Osteoporosis in the elderly with chronic kidney disease[J]. Int Urol Nephrol, 2007, 39:321-331.
  • 6Grotz WH, Mundinger FA, Gugel B, et al. Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients[J]. Transplantation, 1994,58: 912-915.
  • 7朴俊红,庞莲萍,刘忠厚,向青,苏南,潘子昂,郭亦超,李芳芳,李扶刚,刘京萍,陈仲景,王晓敏,扈英伟,张燕晴,王晓红,程晓光.中国人口状况及原发性骨质疏松症诊断标准和发生率[J].中国骨质疏松杂志,2002,8(1):1-7. 被引量:287
  • 8Atsumi K, Kushida K, Yamazaki K, et al. Risk factors for vertebral fractures in renal osteodystrophy[J]. Am J Kidney Dis, 1999,33:287-293.
  • 9Mann ML, Thornley-Brown D, Campbell R. The effect of peritoneal dialysate on DXA bone densitometry results in patients with end stage renal disease[J]. J Clin Densitom, 2008.11:532-536.
  • 10Grzegorzewska AE, Mlot-Michalska M. Influence of age and sex on bone mineral density in dialysis patients[J]. Adv Perit Dial, 2007,23:77-81.

二级参考文献26

共引文献286

同被引文献60

  • 1修晓雨.不同运动处方对人体骨密度及基本体质指标的影响[J].中国临床康复,2005,9(20):174-175. 被引量:11
  • 2<活性维生素D的合理应用>专家协作组.活性维生素D在慢性肾脏病继发性甲旁亢中合理应用的专家共识(修订版)[J].中华肾脏病杂志,2005,21(11):698-699. 被引量:97
  • 3孙宇,崔燎.心血管疾病与骨质疏松[J].中国骨质疏松杂志,2007,13(7):520-523. 被引量:14
  • 4Isaia GC, Tamone C, Ravazzoli M. Fractures and chronic renal insufficiency. G hal Nefrol, 2008,25 ; 57 - 65.
  • 5Mann ML, Thornley- Brown D, Campbell R. The effect of peritoneal dialysate on DXA bone densitometry results in patients with end-stage renal disease. J Clin Densitom, 2008, 11 : 532-536.
  • 6Ersoy FF. Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol, 2007,39 : 321-331.
  • 7Bergner R, Henrieh D, Hoffmann M, et al. Treatment of reduced bone density with ibandronate in dialysis patients. J Nephrol, 2008, 21:510-516.
  • 8Ersoy FF, Passadakis SP, Tam P, et al. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab, 2006,24: 79-86.
  • 9Jeong JU, Lee HK, Kim YJ, et al. Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients. Clin Nephrol, 2010, 74:336-342.
  • 10Kadlroglu AK, Turgutalp K, Ydmaz Z, et al. The frequency of osteoporosis in hemodialysis and continuous ambulatory peritoneal dialysis patients according to PTH levels after active vitamin D therapy during the two years period. Dtlzce Tip Dergisi , 2010, 12:37-42.

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部